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Involucrin is a recently recognized structural compo-
nent of mature squamous epithelial cells. We examined 
involucrin expression using an immunoperoxidase tech-
nique in normal skin and in a variety of epidermal 
hyperplasias and neoplasms to determine whether dis-
tinctive staining patterns existed within these lesions. 
Four patterns of reactivity were observed: diffuse intra-
cellular staining typical of keratinocytes of the upper 
third of normal epidermis and epidermal hyperplasias 
and benign neoplasms; staining at cell borders, seen 
principally in benign epidermal neoplasms; patchy 
staining characteristic of squamous cell carcinoma in 
situ; and absence of staining in benign and neoplastic 
basaloid epithelium. Invasive nests of squamous cell car-
cinomas were negative for involucrin reactivity, 
-whereas pseudoinvasive tongues of epithelium at the 
bases of keratoacanthomas were focally positive. These 
results suggest that immunoperoxidase staining for in-
volucrin may be useful in distinguishing certain benign 
froiD malignant epidermal neoplasms as well as in un-
derstanding the altered maturation and kinetics of pro-
liferative processes afflicting keratinocytes. 
Involucrin is a soluble cytoplasmic protein synthesized in 
human squamous epithelial cells [1] . In normal epidermis, this 
protein is not expressed in the more basal layers [1 ,2L but is 
present in the maturing cells of the upper stratum spmosum 
a nd stratum granulosum, and subsequently app~ars to become 
incorporated into the protein envelope immed1at:l.y beneath 
the cellular plasma membrane. This envelope IS VISible as the 
10-nm marginal band in electron micrographs of mature squa-
mous epithelial cells after treatment with osmium [3,4L and is 
stabilized by calcium-dependent transglutaminase cross-link-
ing [5 ,6]. Immunologically and biochemically unrel.ated to ~er­
atin involucrin is a distinctive marker for a stage m keratmo-
cyte' maturation that immediately precedes the final events of 
terminal differentiation [1,7-9]. 
Recent studies have shown that expression of involucrin is 
altered in neoplastic conditions, a phenomenon of potential 
diagnostic utility. In the uterine cervix, for example, immature 
squamous metaplasia and flat condylomata stain po_sitively for 
involucrin by the immunoperoxidase technique, wh1le the ma-
jority of dysplasias are negative [10]. Cultured cells from human 
squamous cell carcinomas and oral cavity mucosa are defective 
in envelope synthesis [11], and recent observations in our 
laboratory suggest that involucrin expression in invasive squa-
mous cell carcLnomas is markedly diminished in vivo. 
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The purpose of this study is to document the patterns of 
involucrin staining in norma l human epidermis and in a variety 
of epidermal hyperplasias, benign neoplasms, and malignant 
tumors. We hypothesize that if involucrin is a marker of normal 
keratinocyte differentiation , its expression may be altered or 
diminished in lesions characterized by proliferation of less 
differentiated basaloid or malignant cells. The observations 
reported herein document the patterns of immunoperoxidase 
staining using an anti-involucrin antiserum in normal and 
diseased human skin and support the concept that the expres-
sion of involucrin can be used as an indicator of keratinocyte 
differentiat ion and of malignant transformation. 
MATERIALS AND METHODS 
Lesion., Studied 
A total of 5 specimens of normal human ski n and 58 specimens of 
epidermal hyperplas ias, benign neoplasms, and malignant. tumors from 
the surgical material of the Brigham and Women's Hospital (Boston) 
were examined. All specimens had been fixed in 10% neutra l buffe red 
formalin for 2- 8 h (most specimens fixed for approximate ly 4 h), 
dehydrated routinely, and embedded in paraffin. All were site matched 
to include only biopsies of lesions from the neck, trunk, or upper a rm, 
and all diagnoses were confirmed by a dermatopathologist (G.F.M.). 
Antiserum 
The primary antiserum was the rabbit antihuman involucrin de-
scribed previously [1]. This ant iserum is directed against involucrin 
that was chromatographically purified from cultured human epidermal 
ce lls and shown to be homogeneous in molecular weight and isoelectric 
point by gel electrophoresis. The antise rum forms a precipitin band in 
Ouchterlony immunodiffusion plates with less than 1 11g of purified 
involucrin. Nonspecific binding to other proteins of kerat.inocytes or 
dermal fibroblasts is not detectable and no binding to involucrin is 
detected in preimmune serum or ant iserum absorbed with purified 
envelopes. 
lmmunoperoxida.se Techniques 
Details of the immunoperoxidase procedure employed have been 
described previously [1 2] . Paraffin-embedded tissue sections, 4- 6 11m 
thick were deparaffinized in xylene a nd incubated with rabbit antihu-
man involucrin (d ilu t ion 1:1000) for 30 min, fo llowed by sequentia130-
min incubations with swine anti rabbit immunoglobulin antiserum { 1:30 
dilution, Dakopat.ts, Copenhagen; US distributor: Accurate Chemical 
and Scient ific Corp. , Westbury, New York) and horseradish peroxidase 
rabbit anti-horseradish peroxidase {PAP) immune complexes {1:1000 
dilution , Cappel Laboratories, Coch ranville, Pennsylvania). Sections 
were t hen incubated with a solut ion containing 3,3' -diaminobenzidine 
t.etrahydrochloride (Aldrich Chemical Co .. Milwaukee, Wisconsin; 6 
mg/10 ml of 0.1 M Tris buffer at pH 7.6), and hydrogen peroxide (0.1 
ml /10 ml Tris buffer) to visualize the s ite of antibody localization. 
Sections were counterstained with methyl green and mounted with 
Permoun t. Control sections ut ilizi ng either preimmune rabbit serum 
or immune rnbbit serum that had been absorbed with purified keratin-
ocyte envelopes were processed and in al l cases were consistently 
negative. A section of normal sk in was processed as a positive control 
for each case. 
Cha.ra.cteriza.tion of lmmunorea.ctiuity 
All sections were exam ined by 2 observers us ing light microscopy. 
Staining was characte ri zed by location (intrace llula r, apparent cell 
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TABLE I. Histology and involucrin reactivity in 63 biopsies of normal and lesional shin 
Lesion histology 
Normal 
Psoriasis 
Lichen planus 
Lupus erythematosus• 
Seborrheic keratosis 
Pilar cysts 
Verruca vulgaris 
Molluscum contagiosum 
Keratoacanthomas 
Actinic keratosis 
Squamous cell carcinoma, 
in situ 
Squamous ce ll carcinoma, 
invasive 
Basal cell carcinoma 
Total 
No. 
5 
6 
2 
2 
8• 
4 
5 
6 
8 
5 
6 
3 
3 
Site 
Back (4), neck (1) 
Back (3), abdomen (3) 
Back 
Back (1) , shoulder (1) 
Shoulder (4), neck (2), back 
(1) , arm (1) 
Back (2), shoulder (1), arm (1) 
Neck (3), shoulder (1) , abdo-
men (1) 
Abdomen (3) , chest (1), back 
(1), neck (1) 
Shoulder (4), back (2), a rm (2) 
Shoulder (2), neck (1), back 
(1), arm (1) 
Back (3), neck (1), shoulder 
(1) , arm (1) 
Arm (2), neck (1) 
Back (1), chest (1), arm (1) 
• Epidermis atrophic, not hyperplastic . 
• One case <; linica lly was an epidermal nevus. 
Involucrin reactivity 
3-4+; upper third 
2-3+; upper two-thirds 
2-3+; all levels 
3-4+; suprabasal 
2-3+ ; upper one-sixth to two-
thirds 
3- 4+; suprabasal to all levels 
2- 3+; suprabasal 
2-3+; upper two-thirds 
3-4+; upper two-thirds to supra-
basal; positive in pseudoinva-
sive lobules at base 
2-3+; upper t hird to suprabasal 
2-3+; upper one-sixth to two-
thirds 
2-3+; upper half to two-thirds; 
negative in invasive lobules at 
base 
Negative in tumor; focally posi-
tive squamoid zones 
'<:-- •, 
- ') -.·.:- F 
\. 
Pattern 
Intrace llular, uniform 
In tracellular and cell borders 
uniform ' 
Int racellular, uniform 
Intracellular, uniform 
Intrace llular and ce ll borders 
uniform ' 
Intracellular 
Intracellula r and ce ll borders 
uniform ' 
Intracellular, uniform 
Intracellular, uniform 
Intracellular a nd cell borders 
uniform ' 
Int racellular and cell borders 
patchy ' 
Intrace llular, focally patchy 
Intracellular in squamoid zones 
only 
FIG 1. Normal human epidermis, formalin-fixed, paraffin section. Immunoreactivity for involucrin is localized to the upper third of the 
epidermis (A) , the acrosyringium (A,B) and dermal eccrine duct (B); the eccrine secretory coil (B, inset) does not stain. In hair follicles (C,D ) 
involucrin staining is restricted to the ce lls lining the infundibulum and sebaceous duct (C) and the layers of inner root sheath (D). Apocrine 
ducts originating from hair follicles stain (E, upper left-hand corner), while the secretory portion of the glands do not stain (F). (lmmunoperoxidase 
technique; methyl green counterstain; A,E,F: x 86; B,D: X 232; C: X 38; B, inset: x 370.) 
border), distribution (patchy vs di ffuse), extent of staining, and involve-
ment of epidermal appendages. In addition, t he intensity of staining 
was judged relative to negative and positive controls on a scale ranging 
from 0 fo r negative staining to 4+ for the most in tense. Positively 
sta ined ce lls were described as either squamoid (large, polyhydral cells) 
or basa loid (small, rounded to ovoid cells ). 
RESULTS 
The lesional histology and patterns of involucrin reactiVIty 
are summarized in Table I. In normal skin (Fig lA) approxi -
mately the upper third of the epidermis stained intracellularly 
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for involucrin, whereas basal keratinocytes and immediately 
suprabasal layers of the stratum spinosum did n?t stain . . The 
boundary between positively stained and negattvely stamed 
areas was distinct. Cells staining positively for involucrin in 
normal epidermal appendages included the lining epithelium of 
the distal portion of the dermal eccrine duct and acrosyringium, 
the lining cells of the apocrine duct, and the innermost lining 
cells of the follicular infundibulum and isthmus, as well as the 
cells forming the inner root sheath (Fig lB-E). The pattern of 
reactivity within these structures was similar in intensity and 
distribution to that observed in the epidermis. Cells forming 
the outer root sheaths of hair follicles as well as those forming 
the eccrine and apocrine secretory segments were negative (Fig 
lB-D,F). 
Four patterns of staining were recognized. The. first was 
homogeneous intracellular staining. that c.ha~actenzed. areas 
composed of cells with squamous dJffer~nttatJOI_l , both 1~ su-
perficial layers of normal epidermis and m a vanety ?f epider-
mal hyperplasias and benign neoplasms (Table I, Ftg 2A) . A 
second pattern was typical of basaloid epithelium and showed 
confluent zones devoid of staining. This pattern was seen in 
the lower layers of normal epidermis and in zones of benign 
epidermal neoplasms characterized by prolifera~ion of basal?id 
keratinocytes, such as seborrheic keratoses <.Fig 2B). A_ thud 
pattern consisted of staining at cell borders Wl.thout s1gn~ficant 
cytoplasmic reactivity by light microscopy (F1g 2C). Thts pa.t-
tern accentuated the intercellular bndges and was observed m 
benign epidermal neoplasms, often in combination with. t.he 
intracellular pattern. The fourth pattern was patchy react1v1ty 
and resembled a mosaic or "checkerboard" of stained and 
unstained cells (Fig 2D). This pattern was found only in 
squamous cell carcinomas of both in situ and invasive typ~s. 
For all patterns, benign epidermal neoplasms and hyperplastas 
with squamoid differentiation generally showed less discrete 
compartmentalization of involucrin immunoreactivity than in 
normal skin, where the boundary between reactive and. unreac-
tive cells was abrupt. lnvolucrin was not detected m areas 
where proliferation of basaloid cells was maintained along the 
basement membrane zones. However, in inflammatory disor-
ders characterized by "squamatization" of the basal layer, as in 
lichen planus, all layers of the epidermis stained. 
Unlike normal skin, hyperplasias, and benign neoplasms, 
most of which had confluent zones of intense involucrin reac-
tivity (Fig 3A-D), squamous cell carcinomas showed patchy or 
negative stammg for involucrin within squamoid cells (Fig 
3E,F). In invasive squamous cell carcinomas, most invasive 
lobules at the bases of lesions did not react with antiserum for 
involucrin , whereas invasive lobules of histologically similar 
keratoacanthomas showed reactivity (Fig 30-J) . Basal cell 
carcinomas were uniformly negative for involucrin, except in 
rare foci of squamoid differentiation (Fig 3K,L). 
The patterns of reactivity for involucrin within lesions did 
not vary within the sites examined. The nature and extent of 
associated inflammation appeared unrelated to involucrin 
expression. 
DISCUSSION 
These results demonst rate that involucrin expression is al-
tered in epidermal proliferat ive lesions. Normal skin exhibits 
involucrin immunoreactivity in t hose cells beneath the stratum 
corneum that are about to undergo terminal differentiation 
(stratum granulosum and upper stratum spinosum). Sharp 
boundaries between immunoreactive cells in the upper layers 
of the epidermis and negative cells of the lower, less differen -
tiated layers were observed. This reflects coordination of a 
normal differentiation program in which discrete epidermal 
compartments of involucrin expression are distinguishable. 
Consistent with their less mature histologic appearance, prolif-
erative lesions formed by basaloid keratinocytes do not express 
detectable immunoreactivity for involucrin except in focal areas 
of squamoid differentiation . As a consequence, basaloid zones 
of benign and malignant neoplasms such as seborrheic kera-
toses and basal cell carcinomas are not distinguishable from 
each other by this criterion. By contrast, involucrin is readily 
detectable in benign lesions characterized by proliferation of 
squamoid epithelium, although it is less discretely compart-
mentalized than in normal skin . Abnormal patterns of involu-
crin reactivity are emphasized in malignant squamoid lesions 
where patchy immunoreactivity contrasts with the more uni-
form and diffuse patterns of reactivity in benign squamoid 
lesions. These alterations in involucrin expression reflect a lack 
of normal cellular coordination in preterminal differentiation 
in benign and malignant proliferations of squamous epithelium. 
Among the squamoid lesions examined, comparison of kera-
toacanthomas with invasive squamous cell carcinomas provided 
the most striking example of differential involucrin expression. 
Light and electron microscopic studies of keratoacanthomas 
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FIG 3. lnvolucrin staining of benign and malignant epithelial disorders. Unlike normal skin (A), epidermal hyperplas ias such as psoriasis (B) 
and benign neoplasms such as verruca vulgaris (C) characterized by proliferation of squa moid epithelial ce lls, have increased immunoreactivity , 
whereas benign basaloid prol iferat ions, such as seborrheic keratoses (D ), have diminished immunoreactivity. Squamous cell carcinomas in s itu 
(E, hematoxylin & eosin) show absent or patchy staining (F, inset) in zones of squamoid proliferation. Although pseudoinvasive lobules at the 
bases of keratoacanthomas (G, hematoxylin & eosin) stain for involucrin (H), invasive squamous ce ll carcinom as (!,hematoxylin & eosin ) do 
not stain (J). Basal cell carcinomas a re not immunoreactive for involucrin (K) except in focal areas of squamoid differentiation (L). (A,F, inset : 
X 370; B,C,D,E,F,K,L: X 86; G,H,I,J: X 132.) 
[13) and squamous cell carcinomas [14) have suggested that no 
single histologic feature or combination of features reliably 
permit differential diagnosis of these tumors. Whether differ-
entia l immunoreactivity for involucrin will aid in separating 
these lesions requires study of a large number of cases and 
careful clinicopathologic follow-up . 
In addition to assessment of involucrin expression in hyper-
plastic and neoplastic processes, it remains to be established 
whether deviations from the normal differentiation program in 
a variety of dermatoses could be ref1ected in a disturbed intrae-
pidermal distribution of involucrin. Characterization of such 
differentiation markers may provide valuable insight not only 
into the histogenesis of these disorders but also into effects of 
treatment. The latter possibili ty is emphasized by the recent 
observation that hydrocortisone and retinyl acetate modulate 
involucrin levels in cultured malignant human keratinocytes 
[15). 
Numerous markers for keratinocyte differentiation presently 
ex ist, some of which rely upon the demonstration of keratin 
proteins of varying molecular weights within human epidermis 
[16). Keratins are found in a variety of epithelial cell types and 
may be useful in characterizing specific differentiation pro-
grams [17-19). Antiserum to involucrin, by contrast, recognizes 
a single protein, which is therefore a simpler marker for kera-
tinocyte differentiation. In our experience, immunoreactivity 
for involucrin is a lso more specific for squamous epithelium 
than staining for keratin intermediate fi lament proteins (20). 
These features, a long with the ability of antibodies directed 
against involucrin to define this protein in formalin-fixed, 
paraffin-embedded tissues, should foster studies of involucrin 
expression in a variety of physiologic processes inf1uencing 
squamous differentiation. Other potential envelope compo-
nents may be useful also, since envelope formation may well 
involve more than a single protein subunit (21]. 
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